Bellecapital International Ltd. raised its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 1,477.8% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 35,563 shares of the semiconductor company's stock after buying an additional 33,309 shares during the period. Synopsys comprises approximately 3.0% of Bellecapital International Ltd.'s investment portfolio, making the stock its 13th biggest position. Bellecapital International Ltd.'s holdings in Synopsys were worth $16,705,000 as of its most recent SEC filing.
A number of other large investors have also recently added to or reduced their stakes in the business. Montag A & Associates Inc. boosted its holdings in Synopsys by 3.8% during the fourth quarter. Montag A & Associates Inc. now owns 3,239 shares of the semiconductor company's stock worth $1,521,000 after buying an additional 118 shares in the last quarter. PKO Investment Management Joint Stock Co boosted its holdings in Synopsys by 30.8% during the fourth quarter. PKO Investment Management Joint Stock Co now owns 8,500 shares of the semiconductor company's stock worth $3,993,000 after buying an additional 2,000 shares in the last quarter. Addison Capital Co bought a new stake in Synopsys during the fourth quarter worth approximately $670,000. PFA Pension Forsikringsaktieselskab bought a new stake in Synopsys during the fourth quarter worth approximately $52,124,000. Finally, Danske Bank A S boosted its holdings in Synopsys by 6.9% during the fourth quarter. Danske Bank A S now owns 93,318 shares of the semiconductor company's stock worth $43,833,000 after buying an additional 6,050 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of analysts recently weighed in on the stock. Morgan Stanley restated an "equal weight" rating and set a $480.00 target price (down from $550.00) on shares of Synopsys in a report on Wednesday, February 25th. Wells Fargo & Company decreased their price objective on shares of Synopsys from $500.00 to $450.00 and set an "equal weight" rating for the company in a research note on Thursday, February 26th. Piper Sandler decreased their price objective on shares of Synopsys from $520.00 to $430.00 and set a "neutral" rating for the company in a research note on Thursday, February 26th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Synopsys in a research note on Thursday, January 22nd. Finally, Rosenblatt Securities decreased their price objective on shares of Synopsys from $560.00 to $530.00 and set a "buy" rating for the company in a research note on Thursday, February 26th. Eight investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $531.00.
Check Out Our Latest Research Report on Synopsys
Synopsys Stock Performance
Synopsys stock opened at $489.02 on Monday. The company has a 50 day moving average price of $430.07 and a 200 day moving average price of $445.71. Synopsys, Inc. has a 52 week low of $376.18 and a 52 week high of $651.73. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.26 and a current ratio of 1.36. The firm has a market capitalization of $93.68 billion, a price-to-earnings ratio of 75.93, a P/E/G ratio of 3.99 and a beta of 1.25.
Synopsys (NASDAQ:SNPS - Get Free Report) last posted its quarterly earnings data on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, topping analysts' consensus estimates of $3.56 by $0.21. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The firm had revenue of $2.41 billion during the quarter, compared to analyst estimates of $2.39 billion. During the same quarter last year, the business posted $3.03 EPS. The company's revenue was up 65.6% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Research analysts forecast that Synopsys, Inc. will post 10.3 EPS for the current year.
About Synopsys
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.